HedgeChatter

  • Home /
  • Tag Archives

MYL

NDX Leads on Biotech Activity…DJIA Lags on TRV, DD, IBM Earnings…ATI, LRCX Gap Higher…Semis Gain

Three of nine sectors moved higher on Tuesday…XLV, XLP and XLY were the strongest sectors and XLE was the weakest.Breadth weakenedas advancers led decliners 1.001 to 1 on the NYSE and decliners led advancers 1.02 to 1 on the NASDAQ.Tuesday – weakened, mixedMonday – strengthened, advancers ledFriday – weakened, decliners ledThursday – weakened, decliners ledWednesday – strengthened, advancers ledSPY down […]

April 21, 2015 ByCS , , , , , , , , , Comments Off on NDX Leads on Biotech Activity…DJIA Lags on TRV, DD, IBM Earnings…ATI, LRCX Gap Higher…Semis Gain read more

Two Stocks Stand Out In Red-Hot But Volatile Biotech Sector

The enticing if volatile biotechs continue to intrigue investors. Some of the stocks in the fast-growing sector are more alluring than many others, but make no mistake: Biotechs should not be ignored!“Biotech stocks are still in favor with investors for all the right reasons: constant M&A, solid clinical data, regulatory reviews, upcoming scientific conferences, selective stock picking, and technical support,” […]

April 21, 2015 ByGene Marcial , , , , , , , , , , Comments Off on Two Stocks Stand Out In Red-Hot But Volatile Biotech Sector read more

KITE Flying High! KITE, JUNO, BLCM, BLUE

KITE Flying High! KITE, JUNO, BLCM, BLUEShares of Kite Pharma, Inc. (KITE) popped nearly +16% today, afterthe company announced acquisition of a privately held Netherlands-based biotechnology company, T-Cell Factory B.V. This may not have been the only reason. Juno Therapeutics (JUNO) said today that it expects to have 10 product candidates in clinical development directed at six different cancer-associated antigens. […]

March 19, 2015 ByHappyTrading , , , , , , , , , , , Comments Off on KITE Flying High! KITE, JUNO, BLCM, BLUE read more

MYLAN INC. Financials

moreView todays social media effects on MYLView the latest stocks trending across Twitter. Click to view dashboardSee who Mylan is hiring next, click here to view […]

May 9, 2014 Bystocknews , Comments Off on MYLAN INC. Financials read more

Mylan to Present at the UBS Global Healthcare Conference

[PR Newswire] – PITTSBURGH, May 9, 2014 /PRNewswire/ — Mylan Inc. (MYL), one of the world’s leading generic and specialty pharmaceutical companies, today announced that the company will present at the UBS Global Healthcare Conference on Tuesday, May 20, moreView todays social media effects on MYLView the latest stocks trending across Twitter. Click to view dashboardSee who Mylan is hiring […]

May 9, 2014 Bystocknews , Comments Off on Mylan to Present at the UBS Global Healthcare Conference read more

Mylan to Present at the BofA Merrill Lynch 2014 Health Care Conference

[PR Newswire] – PITTSBURGH, May 9, 2014 /PRNewswire/ — Mylan Inc. (MYL), one of the world’s leading generic and specialty pharmaceutical companies, today announced that the company will present at the BofA Merrill Lynch 2014 Health Care Conference on We moreView todays social media effects on MYLView the latest stocks trending across Twitter. Click to view dashboardSee who Mylan is […]

May 9, 2014 Bystocknews , Comments Off on Mylan to Present at the BofA Merrill Lynch 2014 Health Care Conference read more

Supreme Court Chief Justice Denies Teva’s Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for Mylan to Launch at Market Formation

[PR Newswire] – PITTSBURGH, April 18, 2014 /PRNewswire/ — Mylan Inc. (MYL) today announced that Supreme Court Chief Justice Roberts has denied Teva’s application for an injunction seeking to prevent Mylan’s launch of a generic version of Copaxone® pend moreView todays social media effects on MYLView the latest stocks trending across Twitter. Click to view dashboardSee who Mylan is hiring […]

April 19, 2014 Bystocknews , Comments Off on Supreme Court Chief Justice Denies Teva’s Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for Mylan to Launch at Market Formation read more